[Course and prognosis of levels of CD4 molecules in HIV-infected patients]

J Pinilla Moraza1, F Antón Botella, P Labarga Echeverría

  • 1Servicio de Medicina Interna, Complejo Hospitalario San Millán-San Pedro, Logroño, La Rioja.

Anales De Medicina Interna (Madrid, Spain : 1984)
|July 1, 1997
PubMed

Insights

In HIV patients, both CD4 lymphocyte counts and CD4 molecule concentration decrease over time. CD4 molecule concentration is a valuable prognostic marker for disease progression, similar to CD4 lymphocyte counts.

Area of Science:

  • Immunology
  • Virology
  • Clinical Medicine

Background:

  • Human Immunodeficiency Virus (HIV) infection leads to a decline in immune function.
  • CD4+ T lymphocytes are critical for immune response and are a primary target of HIV.
  • Monitoring CD4 cell counts is standard for assessing HIV disease progression.

Purpose of the Study:

  • To measure CD4 molecule concentration on lymphocyte surfaces in HIV-infected patients.
  • To track the evolution of CD4 molecule concentration over one year.
  • To evaluate CD4 molecule concentration as a prognostic marker for HIV disease progression compared to CD4 lymphocyte counts.

Main Methods:

  • Collected clinical and analytical data from 107 HIV patients, with 64 completing one year of follow-up.
  • Measured CD4 molecule concentration using immunoassay and CD4 cell counts.
  • Classified patients based on initial CD4 counts and clinical status (asymptomatic, AIDS-related complex, AIDS).

Main Results:

  • A significant decrease in T4 lymphocytes and CD4 molecules was observed in the overall population and specific subgroups.
  • Progressors showed significantly lower mean T4 lymphocyte counts (140/mm3) and CD4 molecule concentrations (3.87 pmol/l) compared to non-progressors.
  • In asymptomatic patients, only the decrease in CD4 molecule concentration reached statistical significance.

Conclusions:

  • Both CD4 lymphocyte count and CD4 molecule concentration decline over time in HIV-infected individuals.
  • CD4 molecule concentration serves as a prognostic marker for HIV disease progression, comparable in value to CD4 lymphocyte counts.
  • The measurement of CD4 molecule concentration offers a similar prognostic utility to CD4 lymphocyte enumeration in HIV management.
Abstract